CG
BIO icon

Cutler Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Cutler Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-400
Closed -$298K – 5378
2021
Q3 		$298K Buy
+400
New +$300K 0.01% 1104
2017
Q2 		– Sell
-35
Closed -$6K – 6348
2017
Q1 		$6K Sell
35
-2,674
-99% -$515K ﹤0.01% 4507
2016
Q4 		$493K Buy
2,709
+210
+8% +$35.8K 0.02% 699
2016
Q3 		$409K Buy
2,499
+2,470
+8,517% +$375K 0.02% 712
2016
Q2 		$4K Sell
29
-1,525
-98% -$218K ﹤0.01% 5078
2016
Q1 		$212K Buy
+1,554
New +$204K 0.01% 978

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Cutler Group's BIO Position: Q4 2021 in Review

Cutler Group sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2021, closing a stake of 400 shares — an estimated $298K sold.

Cutler Group first reported a position in BIO in Q1 2016 and held it in 6 quarters. The position peaked at $493K in Q4 2016. 533 funds tracked by Wall St. Rank hold BIO as of Q4 2021.

  • Cutler Group reported no remaining Bio-Rad Laboratories Class A position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 400 Bio-Rad Laboratories Class A shares in Q4 2021, an estimated $298K.
  • Cutler Group first reported a position in Bio-Rad Laboratories Class A in Q1 2016 and held it in 6 quarters.
  • Cutler Group's Bio-Rad Laboratories Class A position peaked at $493K in Q4 2016.
  • 533 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.